CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $25.93 ($77,793)
- 4 Grant or award President and CEO acquired 302 shares (grant or award)
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $26.52 ($79,562)
- 4 Open-market sale President and CEO sold 19,578 shares at $26.55 ($519,743)
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $28.12 ($84,360)
- 4 Open-market sale Director sold 5,000 shares at $31.93 ($159,642)
- 10-K/A Report 10-K/A
- 8-K Event Results of operations
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Open-market sale Director sold 16,181 shares at $30.00 ($485,466)
- 4 Open-market sale Chief Medical Officer sold 16,160 shares at $30.00 ($484,800)
Page 27 of 41 · 801 filings